<p>IQR: Interquartile range, NA: not applicable.</p>a<p>Not vaccinated according to vaccine records and the questionnaires.</p>b<p>Had decided not to get vaccinated because they knew they were antibody positive, this group is distinct from the “0 doses” group.</p>c<p>Stated that they were vaccinated in the questionnaire but no vaccine record on number of doses or dates of vaccination were available.</p
<p>Vaccinated participants collected 1–2 months after 3<sup>rd</sup> dose and factors affecting vacc...
<p>Footnote: Relative risks (RR) were approximated by the incidence rate ratio, adjusted for presenc...
a<p>: Vaccinated with at least 1 dose of measles containing vaccine.</p>b<p>: Confirmed measles: Lab...
(a) Excludes 19 participants who did not answer the question of vaccination status and were not incl...
Individuals were considered fully vaccinated based on vaccine registry (WIR/WEDSS) data if the regis...
<p>SPR and GMT in relation to number of vaccine doses (0–5), or previous TBE disease. The “0(ab)” gr...
<p>Vaccine effectiveness is 92.9% and corresponding 95% confidence intervals are (66.6%, 98.5%).</p>...
<p><i>P</i>-values were determined by Pearson’s chi-square test. NC, not calculated.</p>a<p>N = 2158...
Respondents answered questions in Block 1 to Block 5 before reporting their vaccination registration...
a<p>Individuals could contribute person-time to more than one category.</p>b<p>For determination of ...
<p><sup><i>a</i></sup> Median (inter-quartile range, IQR) for immune measures against vaccine (HPV16...
<p>NOTE. Data are no. of participants (%) with data available, unless otherwise indicated. IQR, inte...
Background: Vaccinations are the most effective method for preventing infectious diseases. Massive i...
<p>N/A indicates not assessed.</p><p>As discussed above, the NHWS is conducted once per quarter for ...
†<p>Data of vaccination status were available in only 1323 out of 1417 patients.</p>‡<p>Not applicab...
<p>Vaccinated participants collected 1–2 months after 3<sup>rd</sup> dose and factors affecting vacc...
<p>Footnote: Relative risks (RR) were approximated by the incidence rate ratio, adjusted for presenc...
a<p>: Vaccinated with at least 1 dose of measles containing vaccine.</p>b<p>: Confirmed measles: Lab...
(a) Excludes 19 participants who did not answer the question of vaccination status and were not incl...
Individuals were considered fully vaccinated based on vaccine registry (WIR/WEDSS) data if the regis...
<p>SPR and GMT in relation to number of vaccine doses (0–5), or previous TBE disease. The “0(ab)” gr...
<p>Vaccine effectiveness is 92.9% and corresponding 95% confidence intervals are (66.6%, 98.5%).</p>...
<p><i>P</i>-values were determined by Pearson’s chi-square test. NC, not calculated.</p>a<p>N = 2158...
Respondents answered questions in Block 1 to Block 5 before reporting their vaccination registration...
a<p>Individuals could contribute person-time to more than one category.</p>b<p>For determination of ...
<p><sup><i>a</i></sup> Median (inter-quartile range, IQR) for immune measures against vaccine (HPV16...
<p>NOTE. Data are no. of participants (%) with data available, unless otherwise indicated. IQR, inte...
Background: Vaccinations are the most effective method for preventing infectious diseases. Massive i...
<p>N/A indicates not assessed.</p><p>As discussed above, the NHWS is conducted once per quarter for ...
†<p>Data of vaccination status were available in only 1323 out of 1417 patients.</p>‡<p>Not applicab...
<p>Vaccinated participants collected 1–2 months after 3<sup>rd</sup> dose and factors affecting vacc...
<p>Footnote: Relative risks (RR) were approximated by the incidence rate ratio, adjusted for presenc...
a<p>: Vaccinated with at least 1 dose of measles containing vaccine.</p>b<p>: Confirmed measles: Lab...